Modified Si-Miao-San extract inhibits the release of inflammatory mediators from lipopolysaccharide-stimulated mouse macrophages

Journal of Ethnopharmacology

Volumn 129, Issue 1, 2010, Pages 5-9

  Fan, Jinghua ^a   Liu, Kang ^a   Zhang, Zhongai ^b   Luo, Tianjiong ^b   Xi, Zhilei ^b   Song, Junna ^a   Liu, Baolin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Nanjing Municipal Hospital of Traditional Chinese Medicine   (China)

Author keywords

LPS induced inflammation; Macrophages; Modified Si Miao San

Indexed keywords

HERBACEOUS AGENT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; SI MIAO SAN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AUTACOID; I KAPPA B; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME PHOSPHORYLATION; GENE EXPRESSION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; ANGIOSPERM; ANIMAL; DRUG EFFECTS; GENETICS; METABOLISM; PHOSPHORYLATION;

ANGIOSPERMS; ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUGS, CHINESE HERBAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; I-KAPPA B PROTEINS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951976569     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.02.002     Document Type: Article

References (17)

1. Aldhahi W., Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Current Diabetes Reports 2003, 3:293-298.
2. Andersen K., Pedersen B.K. The role of inflammation in vascular insulin resistance with focus on IL-6. Hormone Metabolism Research 2008, 40:635-639.
3. Barak V., Kalickman I., Halperin T., Birkenfeld S., Ginsburg I. PADMA-28, a Tibetan herbal preparation is an inhibitor of inflammatory cytokine production. European Cytokine Network 2004, 15:203-209.
4. Dumitru C.D., Ceci J.D., Tsatsanis C., Kontoviannis D., Stamatakis K., Lin J.H., Patriotis C., Jenkins N.A., Copeland N.G., Kollias G., Tsichlis P.N. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 2000, 103:1071-1083.
5. Evans C.H. Nitric oxide: what role does it play in inflammation and tissue destruction. Agents and Actions 1995, 47(Suppl.):107-116.
6. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cellular Signal 2001, 13:85-94.
7. Hotamisligil, G.S., Shargill, N.S., S. B.M., 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91.
8. Hsu H.Y., Wen M.H. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. Journal of Biological Chemistry 2002, 277:22131-22139.
9. Jieyun J., Chunxiang Z., Qiang X. Alleviating effects of Si-Ni-San, a traditional Chinese prescription, on experimental liver injury and its mechanisms. Biological and Pharmaceutical Bulletin 2003, 8:1089-1094.
10. Kim S.J., Jeong H.J., Moon P.D., Lee K.M., Lee H.B., Jung H.J., Jung S.K., Rhee H.K., Yang D.C., Hong S.H., Kim H.M. Anti-inflammatory activity of gumiganghwaltang through the inhibition of nuclear factor-kappa B activation in peritoneal macrophages. Biological and Pharmaceutical Bulletin 2005, 2:233-237.
11. Lee J.H., Haeng Sun Jung H.S., Giang P.M., Jin X., Lee S., Son P.T., Lee D., Hong Y.S., Lee K., Lee J.J. Blockade of nuclear factor-B signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera. The Journal of Pharmacology and Experimental Therapeutics 2006, 316:271-278.
12. 2 and tumor necrosis factoralpha in RAW264.7 murine macrophages. Bioscience Biotechnology and Biochemistry 2003, 67:1056-1062.
13. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. The New England Journal of Medicine 2000, 12:836-843.
14. Tarighi B., Kurum T., Demir M., Azcan S.N. The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients. Canadian Journal of Cardiology 2007, 23:651-655.
15. Verma S., Shu-Hong L., Badiwala M.V., Weasel R.D., Fedak P.W., Ren-Ke L., Dhillon B., Mickle D.A.G. Endothelin antagnisem and interleikin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002, 105:1890-1896.
16. Yudkin J.S., Stehouwer C.D.A., Emeis J.J., Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arteriosclerosis, Thrombosis, and Vascular Biology 1999, 19:972-978.
17. Zhang G., Ghosh S. Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors. Journal of Endotoxin Research 2000, 6:453-457.